Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma. (Q51383074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Qingqing Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Tao Tao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Fang Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Cuihua Lu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Aiguo Shen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

language of work or name

English

0 references

publication date

14 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

230-238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Dietary sugar intake increases liver tumor incidence in female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

PKM2 contributes to cancer metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Glucose metabolism disorders in cancer patients in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Translocation of HSP27 into liver cancer cell nucleus may be associated with phosphorylation and O-GlcNAc glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

O-GlcNAcylation of kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

YB-1 protein: functions and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Loss of CDH1 up-regulates epidermal growth factor receptor via phosphorylation of YBX1 in non-small cell lung cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Treatment algorithms for managing hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

The emerging significance of O-GlcNAc in cellular regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.10.011

10.1016/J.YEXCR.2016.10.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27751836%20AND%20SRC:MED&resulttype=core&format=json